The Medical Products Division of the Bhutan Food and Drug Authority (BFDA) is pleased to present the draft Guideline for WHO-Collaborative Registration Procedure for IVDs 2025 for your review and feedback.
We kindly request you to provide your comments, suggestions, or recommendations directly within the documents where “commentary access” has been granted. Please refer to the link (Guideline for WHO-Collaborative Registration Procedure for IVDs 2025) to access the draft strategy. We would appreciate receiving your inputs by 11 March 2026.
Thank you for your valuable input and cooperation